Medicinal Chemistry
Our medicinal chemistry capabilities are designed to accelerate the identification and optimization of potential drug candidates through a combination of rational molecular design, structure–activity relationship (SAR) analysis, and rapid synthesis of target compounds. We understand that timely, high-quality chemistry is essential for informed decision-making in drug discovery.
Core medicinal chemistry capabilities:
- Hit-to-lead support: Transforming initial screening hits into chemically tractable lead     compounds with optimized properties.
- Lead optimization: Iterative design and synthesis to improve efficacy, reduce off-target    effects, and enhance drug-like characteristics.
- SAR-driven analog generation: Producing focused libraries of analogs to explore key      molecular interactions and optimize activity profiles.
- Scaffold modification and molecular refinement: Designing modifications that retain     activity while improving solubility, stability, or pharmacokinetic properties.
- Focused libraries for decision-making: Strategically designed compound sets to         support rapid biological evaluation and prioritization.